Влияние различных инстилляционных гипотензивных режимов на развитие и прогрессирование синдрома «сухого глаза»
А. В. Куроедов, З. М. Нагорнова, А. В. Селезнев et al. · Национальный журнал глаукома · 2017
PURPOSE: To determine the degree of influence of different local hypotensive instillation regimens on the development and progression of corneal-conjunctival xerosis in patients with different stages of primary open-angle glaucoma (POAG). METHODS: 530 people (866 eyes) were included in a database study conducted from January to May 2016. The main group consisted of 398 patients with POAG, the control group included 132 people without POAG. The average age of patients was 68.45 (62.7; 74.5) years in the main group, and 60.9 (52.00; 68.8) years in the control group. Ophthalmic examination included tonometry, morphometric and functional analysis. Examination with the purpose to verify «dry eye» syndrome (DES) included tear film break-up time test (TBUT), Schirmer’s test, lissamine green staining and ocular surface disease index (OSDI) test. RESULTS: To determine the effect of different modes of local hypotensive drug therapy on the severity of DES symptoms all glaucoma patients were divided into two groups based on glaucoma duration: from 0.5 to 2 years (282 eyes) and from 2 to 4 years duration of glaucoma (275 eyes). To avoid problems related to differences in the average age in the main and control groups, comparative analysis was conducted in the age groups of 50-60, 61-70 and 71-80 years. The comparability of the results in both groups of patients was established. We established that maximum medication regimen was marked by a pronounced depression of functional indices of tears and tear film despite topical treatment duration. OSDI was significantly higher in patients who received prostaglandin analogues. It was established that the DES intensity was significantly higher in patients with advanced stages of the disease. CONCLUSION: The findings prove that ophthalmologists should consider the possible onset and progression of DES when they plan glaucoma medical treatment strategy.
Cited by 0 works.